Sequential treatment of icotinib after first-line pemetrexed in advanced lung adenocarcinoma with unknown EGFR gene status.
about
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma.Therapeutic management options for stage III non-small cell lung cancer.The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma.Pemetrexed-carboplatin with intercalated icotinib in the treatment of patient with advanced EGFR wild-type lung adenocarcinoma: A case reportSequentially administrated of pemetrexed with icotinib/erlotinib in lung adenocarcinoma cell lines in vitro.
P2860
Sequential treatment of icotinib after first-line pemetrexed in advanced lung adenocarcinoma with unknown EGFR gene status.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sequential treatment of icotin ...... with unknown EGFR gene status.
@ast
Sequential treatment of icotin ...... with unknown EGFR gene status.
@en
type
label
Sequential treatment of icotin ...... with unknown EGFR gene status.
@ast
Sequential treatment of icotin ...... with unknown EGFR gene status.
@en
prefLabel
Sequential treatment of icotin ...... with unknown EGFR gene status.
@ast
Sequential treatment of icotin ...... with unknown EGFR gene status.
@en
P2093
P2860
P1476
Sequential treatment of icotin ...... with unknown EGFR gene status.
@en
P2093
Jianying Zhou
Weijia Fang
Yulong Zheng
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2014.07.18
P577
2014-07-01T00:00:00Z